These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy. Klamroth R; Gottstein S; Essers E; Landgraf H Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort. Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090 [TBL] [Abstract][Full Text] [Related]
4. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures. Mar PL; Familtsev D; Ezekowitz MD; Lakkireddy D; Gopinathannair R Int J Cardiol; 2016 Jan; 202():578-85. PubMed ID: 26447666 [TBL] [Abstract][Full Text] [Related]
11. Periprocedural bridging anticoagulation: current perspectives. Palaniswamy C; Selvaraj DR Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672 [TBL] [Abstract][Full Text] [Related]
12. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists]. Angelo M; Stockner I; Wiedermann CJ Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707 [TBL] [Abstract][Full Text] [Related]
13. Update on perioperative bridging in patients on chronic oral anticoagulation. Faltas B; Kouides PA Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1533-9. PubMed ID: 19954315 [TBL] [Abstract][Full Text] [Related]
14. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Larson BJ; Zumberg MS; Kitchens CS Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777 [TBL] [Abstract][Full Text] [Related]
15. [Perioperative management of platelet function and anticoagulation in geriatric patients]. Lenzen-Großimlinghaus R Chirurg; 2022 Mar; 93(3):266-273. PubMed ID: 34665284 [TBL] [Abstract][Full Text] [Related]
16. [Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging]. MMW Fortschr Med; 2005 Jun; 147(22):51. PubMed ID: 15977637 [No Abstract] [Full Text] [Related]
17. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon. Beinema M; Brouwers JR; Schalekamp T; Wilffert B Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230 [TBL] [Abstract][Full Text] [Related]
18. [Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?]. Buerke M; Hoffmeister HM Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):105-110. PubMed ID: 28074293 [TBL] [Abstract][Full Text] [Related]
19. Characteristics, treatment and outcome of bleeding after tooth extraction in patients on DOAC and phenprocoumon compared to non-anticoagulated patients-a retrospective study of emergency department consultations. Müller M; Schlittler F; Schaller B; Nagler M; Exadaktylos AK; Sauter TC Clin Oral Investig; 2019 May; 23(5):2273-2278. PubMed ID: 30291493 [TBL] [Abstract][Full Text] [Related]
20. Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach. Douketis JD Hosp Pract (1995); 2011 Oct; 39(4):41-54. PubMed ID: 22056822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]